What We're Reading: Page
Industry reads hand-picked by our editors
Jun 03, 2026
Jun 02, 2026
-
The Financial Times
Growing US reliance on Chinese biotechs prompts national security fears
-
LifeSciVC
Patient-first, America-first: The Case For Global Collaboration
-
The Washington Post
An experimental GLP-1 pushes the limits of weight loss. There are risks.
-
Bloomberg Law
FDA’s Acting Head to Meet Closed-Door With Rare Disease Groups
Jun 01, 2026
May 29, 2026
May 28, 2026
May 27, 2026
-
The Wall Street Journal
Is the Weight-Loss Drug Revolution Causing a Frailty Epidemic?
-
South China Morning Post
China’s drug regulator clears wave of home-grown innovative medicines amid biotech boom
-
Crain’s Chicago
University of Chicago spinout bets $55M on city as Midwest biotech hub
-
The New York Times
A Powerful H.I.V. Drug Lands in Zambia. But Will It Reach Those Who Need It?